Pfizer Historical Income Statement
PFE Stock | USD 26.26 0.26 1.00% |
Historical analysis of Pfizer income statement accounts such as Other Operating Expenses of 28.8 B, Operating Income of 4 B, EBIT of 4 B or Ebitda of 15.4 B can show how well Pfizer Inc performed in making a profits. Evaluating Pfizer income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Pfizer's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Pfizer Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Pfizer Inc is a good buy for the upcoming year.
Pfizer |
About Pfizer Income Statement Analysis
Pfizer Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Pfizer shareholders. The income statement also shows Pfizer investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Pfizer Income Statement Chart
Pfizer Inc Income Statement is one of the three primary financial statements used for reporting Pfizer's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Pfizer Inc revenue and expense. Pfizer Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Pfizer's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 30.4 B, whereas Other Operating Expenses is forecasted to decline to about 28.8 B. Add Fundamental
Total Revenue
Total revenue comprises all receipts Pfizer Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Pfizer Inc minus its cost of goods sold. It is profit before Pfizer operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Pfizer Inc. It is also known as Pfizer overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Pfizer Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Pfizer Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Pfizer's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Pfizer Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. At present, Pfizer's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 30.4 B, whereas Other Operating Expenses is forecasted to decline to about 28.8 B.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 50.5B | 66.0B | 29.3B | 30.4B | Total Revenue | 81.3B | 100.3B | 58.5B | 39.5B |
Pfizer income statement Correlations
Click cells to compare fundamentals
Pfizer Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pfizer income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 4.6B | 3.4B | 3.7B | 3.6B | 6.3B | 6.6B | |
Interest Expense | 1.6B | 1.4B | 1.3B | 1.2B | 2.4B | 2.5B | |
Total Revenue | 51.8B | 41.9B | 81.3B | 100.3B | 58.5B | 39.5B | |
Gross Profit | 41.5B | 33.2B | 50.5B | 66.0B | 29.3B | 30.4B | |
Other Operating Expenses | 37.8B | 33.1B | 61.1B | 63.1B | 54.3B | 28.8B | |
Operating Income | 15.1B | 10.6B | 24.8B | 40.0B | 4.2B | 4.0B | |
Ebit | 15.1B | 10.6B | 24.8B | 40.0B | 4.2B | 4.0B | |
Ebitda | 19.7B | 14.1B | 28.5B | 43.6B | 10.5B | 15.4B | |
Cost Of Revenue | 10.2B | 8.7B | 30.8B | 34.3B | 29.2B | 30.7B | |
Total Operating Expenses | 27.6B | 24.5B | 30.2B | 28.7B | 25.0B | 19.8B | |
Income Before Tax | 17.7B | 7.5B | 24.3B | 34.7B | 1.1B | 1.0B | |
Total Other Income Expense Net | 2.5B | (3.1B) | (522M) | (5.3B) | (3.2B) | (3.0B) | |
Net Income | 16.3B | 7.0B | 22.0B | 31.4B | 2.1B | 2.0B | |
Income Tax Expense | 1.4B | 477M | 1.9B | 3.3B | (1.1B) | (1.1B) | |
Selling General Administrative | 12.1B | 9.8B | 10.7B | 10.9B | 10.8B | 13.7B | |
Research Development | 8.7B | 9.4B | 13.8B | 11.4B | 10.6B | 8.2B | |
Net Income Applicable To Common Shares | 16.3B | 9.6B | 22.0B | 31.4B | 36.1B | 37.9B | |
Discontinued Operations | 4M | 2.6B | (434M) | 6M | 5.4M | 5.1M | |
Net Income From Continuing Ops | 16.3B | 7.0B | 22.5B | 31.4B | 2.2B | 2.1B | |
Non Recurring | 747M | 600M | 802M | 2.3B | 2.1B | 1.3B | |
Non Operating Income Net Other | 4.5B | (663M) | 4.9B | (217M) | (249.6M) | (262.0M) | |
Tax Provision | 1.4B | 477M | 1.9B | 3.3B | (1.1B) | (1.1B) | |
Interest Income | 226M | 538M | 560M | 1.8B | 1.6B | 924.4M | |
Extraordinary Items | 326M | 2.6B | (434M) | 6M | 5.4M | 5.1M | |
Net Interest Income | (1.3B) | (1.4B) | (1.3B) | (987M) | (585M) | (614.3M) | |
Reconciled Depreciation | 6.0B | 4.8B | 3.7B | 3.6B | 6.3B | 4.2B |
Pfizer Investors Sentiment
The influence of Pfizer's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pfizer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Pfizer's public news can be used to forecast risks associated with an investment in Pfizer. The trend in average sentiment can be used to explain how an investor holding Pfizer can time the market purely based on public headlines and social activities around Pfizer Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pfizer's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pfizer's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pfizer's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Pfizer.
Pfizer Implied Volatility | 33.78 |
Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pfizer in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pfizer's short interest history, or implied volatility extrapolated from Pfizer options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pfizer Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Dividend Share 1.64 | Earnings Share 0.37 | Revenue Per Share 10.366 | Quarterly Revenue Growth (0.41) |
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.